title: Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil.
abstract: The human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) associated with the HTLV-I is a well-defined clinical-pathological entity in which the virus and host immune responses contribute to the pathological mechanism. In this study, flow cytometric analysis of whole peripheral blood leucocytes (PBL) was performed to evaluate the immunological status of HTLV-I-infected individuals in an effort to better understand the role of the immune system in the development of HAM/TSP. We have evaluated three groups of infected patients including asymptomatic (AS = 18), ambulatory/oligosymptomatic (AM = 14) and hospitalized HAM/TSP individuals (HO = 42). Noninfected healthy blood donors were used for the control group (NI = 32). Our results demonstrated that the HO group presents an increased percentage of circulating T cells and a decreased percentage of B and natural killer (NK) cells, leading to the highest T/B-cell ratio in comparison with the other groups. Interestingly, while an increased percentage of activated CD4+HLA-DR+ T lymphocytes was observed in both AM and HO, only HO presented higher percentage of activated CD8+HLA-DR+ in combination with the highest CD18 surface expression. This was true for all cell populations analysed, including T lymphocytes, monocytes and neutrophils. Moreover, the HO group was distinguished by a dramatic decrease in the percentage of CD8+CD28+ lymphocytes. Taken together, these findings demonstrate a potent cellular immune activation response involving primarily CD8+ T cells that is concomitant with disease progression in HAM/TSP. We also show that an upregulation of CD18 expression, a hallmark for increased cell migratory potential, might play a critical role in the development/maintenance of HAM/TSP.
authors.affiliation: Laboratório de Doença de Chagas - CPqRR-FIOCRUZ/BH, Minas Gerais, Brazil.
authors.forename: G E A
authors.initials: GE
authors.lastname: Brito-Melo
authors.forename: O A
authors.initials: OA
authors.lastname: Martins-Filho
authors.forename: A B F
authors.initials: AB
authors.lastname: Carneiro-Proietti
authors.forename: B
authors.initials: B
authors.lastname: Catalan-Soares
authors.forename: J G
authors.initials: JG
authors.lastname: Ribas
authors.forename: G W
authors.initials: GW
authors.lastname: Thorum
authors.forename: E F
authors.initials: EF
authors.lastname: Barbosa-Stancioli
mesh_terms: D000328:Adult; D001938:Brazil; D018821:CD18 Antigens / Q000096:biosynthesis; D018106:CD28 Antigens / Q000096:biosynthesis; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D003430:Cross-Sectional Studies; D005260:Female; D005434:Flow Cytometry; D015490:HTLV-I Infections / Q000097:blood* / Q000150:complications / Q000276:immunology; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D006801:Humans; D007962:Leukocytes / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D015493:Paraparesis, Tropical Spastic / Q000097:blood* / Q000150:complications / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology
chemical_list: D018821:CD18 Antigens; D018106:CD28 Antigens